A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
05/21/2015 | Ana-Maria Šimundić
The preanalytical phase is subject to more error than any other part of the testing cycle – what can we do to improve it?
05/20/2015 | Keith Cheng
Curiosity’s road to pathology, zebrafish genetics, genomics and imaging
05/20/2015 | George Kontogeorgos
We Sit Down With George Kontogeorgos, President-Elect of the International Academy of Pathology.
04/28/2015 | Michael Misialek
The major challenge in diagnosing the potential for breast cancer at the premalignant stages lies in recognizing it.
04/28/2015 | Kenneth Bloom
Although the JAMA article (1) claims to have identified a lack of consistency in pathologists’ breast cancer diagnoses, this doesn’t reflect actual clinical practice
04/28/2015 | Michael Schubert
Recent media attention on diagnostic discordance has patients shying away from cancer screening – but are they justified?
04/27/2015 | Michael Schubert
The UK FRCPath Part 2 exam is viewed as a problematic stumbling block by many. Why?
Many hospitals sequence patients’ tumor genomes to personalize their treatment – but without sequencing normal tissue, this can harm rather than heal.
04/27/2015 | Fedra Pavlou
Can negative media reports open up a good opportunity for pathology?
04/27/2015 | Michael Prystowsky
We sit down with Michael Prystowsky, Professor of Pathology, Montefiore Medical Centre, NY, USA.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Lessons from the Power List: Challenges
The Genome Pioneer
The Value of Neuropathology